Arthur Piraux
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Arthur Piraux has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Sébastien Faure
Univ Angers, Fac Sante, Dept Pharm, 16 Blvd Daviers, F-49045 Angers, France
5 shared publications - Aline Ramond-Roquin
Univ Angers, POPS, SFR ICAT, Angers, F-49000, France
4 shared publications Aline Ramond-Roquin
Univ Angers, Univ Rennes, EHESP, IRSET – UMR_S 1085, SFR ICAT
3 shared publicationsSébastien Faure
Univ Angers, Inserm, CNRS, MINT, SFR ICAT
3 shared publications- Elsa Parot-Schinkel
Biostatistics and methodology department, Angers University Hospital, Angers, France
2 shared publications Jakhongir F. Alidjanov
Department of Urology, Pediatric Urology and Andrology, Justus-Liebig University of Giessen, Giessen, Germany
2 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 22 (12) , 1112-1118
Effectiveness of a pharmacist-led protocol to manage cystitis in women, in France: the PharmaCyst’ open-label, multicenter, randomized, controlled, cluster study
- 1 July 2026
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 22 (12) , 1112-1118
Open AccessEffectiveness of a pharmacist-led protocol to manage cystitis in women, in France: the PharmaCyst’ open-label, multicenter, randomized, controlled, cluster study
- 7 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Introduction de la prescription pharmaceutique : étude de la dispensation sous protocole dans la prise en charge de la cystite simple de la femme en France
En France comme ailleurs, les missions attribuées au pharmacien d’officine sont en plein essor ; en témoigne un changement de paradigme, passant du pharmacien dispensateur au pharmacien prescripteur. L’objectif de ce travail de recherche consiste à aborder la prescription pharmaceutique, à travers l’exemple de la dispensation protocolisée dans la prise en charge de la cystite simple de la femme. Cette affection bénigne a été retenue du fait de sa prévalence, et la forte demande exprimée par les patientes à l’égard des pharmaciens. L’analyse de sa prise en charge actuelle révèle des manquements dans le respect des recommandations en vigueur, pouvant contribuer à une antibiorésistance. Un examen de la portée a permis de dresser un état des lieux du déploiement de la prescription pharmaceutique à l’international. Efficacité et efficience ont été observées, mais uniquement au Canada et au Royaume-Uni. L’étude clinique PharmaCyst’ tentera d’évaluer l’efficacité de la prise en charge, par le pharmacien d’officine, des femmes âgées de 18 à 65 ans, présentant des signes fonctionnels urinaire. Cette étude conduite sur le territoire régional des Pays-de-la-Loire, s’appuiera sur un protocole de dispensation et débouchera sur la dispensation d’un antibiotique sans prescription médicale. Le critère de jugement principal sera l’évolution de l’intensité des symptômes des patientes à 3 jours de la prise en charge, évalué par l’Acute cystits symptom score. Ce score est déjà validé sur le plan international, sa traduction française ainsi que sa validation linguistique ont été menées durant ce travail de thèse. Accorder aux pharmaciens d’officine la possibilité de conduire des études cliniques, mais également de mener une activité officinale en parallèle d’un enseignement universitaire, sont des moyens d’améliorer, à terme, l’efficience du système de santé français.
- 7 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Introduction de la prescription pharmaceutique : étude de la dispensation sous protocole dans la prise en charge de la cystite simple de la femme en France
En France comme ailleurs, les missions attribuées au pharmacien d’officine sont en plein essor ; en témoigne un changement de paradigme, passant du pharmacien dispensateur au pharmacien prescripteur. L’objectif de ce travail de recherche consiste à aborder la prescription pharmaceutique, à travers l’exemple de la dispensation protocolisée dans la prise en charge de la cystite simple de la femme. Cette affection bénigne a été retenue du fait de sa prévalence, et la forte demande exprimée par les patientes à l’égard des pharmaciens. L’analyse de sa prise en charge actuelle révèle des manquements dans le respect des recommandations en vigueur, pouvant contribuer à une antibiorésistance. Un examen de la portée a permis de dresser un état des lieux du déploiement de la prescription pharmaceutique à l’international. Efficacité et efficience ont été observées, mais uniquement au Canada et au Royaume-Uni. L’étude clinique PharmaCyst’ tentera d’évaluer l’efficacité de la prise en charge, par le pharmacien d’officine, des femmes âgées de 18 à 65 ans, présentant des signes fonctionnels urinaire. Cette étude conduite sur le territoire régional des Pays-de-la-Loire, s’appuiera sur un protocole de dispensation et débouchera sur la dispensation d’un antibiotique sans prescription médicale. Le critère de jugement principal sera l’évolution de l’intensité des symptômes des patientes à 3 jours de la prise en charge, évalué par l’Acute cystits symptom score. Ce score est déjà validé sur le plan international, sa traduction française ainsi que sa validation linguistique ont été menées durant ce travail de thèse. Accorder aux pharmaciens d’officine la possibilité de conduire des études cliniques, mais également de mener une activité officinale en parallèle d’un enseignement universitaire, sont des moyens d’améliorer, à terme, l’efficience du système de santé français.
- 5 December 2025
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 231, 113035
Perspectives on antibiotic management of diabetic foot osteomyelitis: A scoping review on routes of administration
- 5 December 2025
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 231, 113035
Perspectives on antibiotic management of diabetic foot osteomyelitis: A scoping review on routes of administration
- 20 December 2024
- Published by Elsevier in Actualites Pharmaceutiques
- Vol. 64 (642) , 19
Des pharmaciens d’officine aux multiples compétences
- 20 December 2024
- Published by Elsevier in Actualites Pharmaceutiques
- Vol. 64 (642) , 19
Des pharmaciens d’officine aux multiples compétences
- Open Access
- 3 October 2024
- Published by Springer Nature in Trials
- Vol. 25 (1) , 1-11
Efficacy of a pharmacist care protocol to manage uncomplicated female cystitis in community pharmacies: an open-label, multicenter, randomized, controlled, cluster study: the PharmaCyst’ protocol
Urinary tract infections are common affections, especially for women. Difficult access to a general practitioner to obtain a prescription has led France to offer dispensing under protocol by community pharmacists. The primary objective of this study is to evaluate the effectiveness of a pharmacist care protocol provided to manage women with urinary tract infection symptoms. This objective will be assessed using the Acute Cystitis Symptom Score. PharmaCyst’ is an open-label, multicenter, controlled, cluster-randomized study conducted in the Loire region, France. Women aged between 18 and 65 years presenting to a pharmacy complaining of at least one symptom of an uncomplicated urinary tract infection present over the last 3 days (including burning pain during micturition, dysuria, pollakiuria, urgent urination) will be considered for inclusion. All patients will be contacted on day 3, 10, and month 3. A total of 480 patients need to be recruited for the 24 clusters participating in the research. The quantitative data will be described using means and standard deviations and compared using Student’s t-test. The qualitative data will be described using numbers and percentages and compared using chi2 test (or Fisher’s exact test if necessary). The primary and secondary outcomes analyses will consider the intention-to-treat population. PharmaCyst’ is the first clinical trial conducted in France only by community pharmacists. Its results could lead to an extension of the protocol. The protocol has been approved by the French ethics committee on 2022/12/02 and is registered under the number 49RC22_0240 on ClinicalTrials.gov.
- 3 October 2024
- Published by Springer Nature in Trials
- Vol. 25 (1) , 1-11
Open AccessEfficacy of a pharmacist care protocol to manage uncomplicated female cystitis in community pharmacies: an open-label, multicenter, randomized, controlled, cluster study: the PharmaCyst’ protocol
Urinary tract infections are common affections, especially for women. Difficult access to a general practitioner to obtain a prescription has led France to offer dispensing under protocol by community pharmacists. The primary objective of this study is to evaluate the effectiveness of a pharmacist care protocol provided to manage women with urinary tract infection symptoms. This objective will be assessed using the Acute Cystitis Symptom Score. PharmaCyst’ is an open-label, multicenter, controlled, cluster-randomized study conducted in the Loire region, France. Women aged between 18 and 65 years presenting to a pharmacy complaining of at least one symptom of an uncomplicated urinary tract infection present over the last 3 days (including burning pain during micturition, dysuria, pollakiuria, urgent urination) will be considered for inclusion. All patients will be contacted on day 3, 10, and month 3. A total of 480 patients need to be recruited for the 24 clusters participating in the research. The quantitative data will be described using means and standard deviations and compared using Student’s t-test. The qualitative data will be described using numbers and percentages and compared using chi2 test (or Fisher’s exact test if necessary). The primary and secondary outcomes analyses will consider the intention-to-treat population. PharmaCyst’ is the first clinical trial conducted in France only by community pharmacists. Its results could lead to an extension of the protocol. The protocol has been approved by the French ethics committee on 2022/12/02 and is registered under the number 49RC22_0240 on ClinicalTrials.gov.
- 10 August 2024
- Published by Elsevier in Actualites Pharmaceutiques
- Vol. 63 (638)
profession
- 7 August 2024
- Published by Elsevier in Actualites Pharmaceutiques
- Vol. 63 (638) , 7
Une équipe officinale fin prête pour accompagner la reprise
- 7 August 2024
- Published by Elsevier in Actualites Pharmaceutiques
- Vol. 63 (638) , 7
Une équipe officinale fin prête pour accompagner la reprise
- 22 July 2024
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 64 (6)
The community pharmacist as an independent prescriber: A scoping review
- 22 July 2024
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 64 (6)
The community pharmacist as an independent prescriber: A scoping review
- Open Access
- 3 November 2023
- Published by Springer Nature in BMC Primary Care
- Vol. 24 (1) , 1-11
Factors influencing French community pharmacists’ willingness to participate in research projects: a mixed method study
Background: French community pharmacists are facing an increasing demand to provide a wider range of services to meet the needs of the population. These new missions must be evaluated by primary care research studies. This study aims to explore the factors that influence French community pharmacists’ willingness to participate in research projects. Methods: A mixed-method design was adopted for this study, comprising an initial quantitative online survey followed by semi-directed interviews. The investigation was conducted at two French faculties of pharmacy, Angers and Nantes, involving students in their 6th and final year of pharmacy education, and their community pharmacist tutors. The survey items were based on a study by Saini et al. and participants responded using five-point Likert scales. The semi-directed interviews were conducted after the quantitative analysis, only with volunteer and already graduated community pharmacists. Results: A total of 131 people participated in the quantitative analysis, comprising 75 students and 56 pharmacists. Pharmacists and students agreed on the significance of two key aspects: the research must possess a clear and meaningful purpose, and researchers must keep the pharmacists informed about the study’s results. Among the 27 proposed items, only three showed significantly different results between students and pharmacists. Moreover, 11 semi-structured interviews were conducted. Research in the community pharmacy domain is relatively new for many pharmacists. Despite limited training, their willingness to participate is contingent on being actively involved from the outset, receiving appropriate support and training. However, the research should be seamlessly integrated into their daily practice, without being too time-consuming and administratively burdensome. Time constraints emerged as the main obstacle, along with concerns about the availability of human resources. Pharmacists expressed strong motivation driven by the research topic’s relevance, and its potential impact on patients or the profession. While financial compensation is desirable, it did not appear to be the main criterion for participation in a study. Conclusions: French pharmacists are willing to participate in research projects to improve patient care and develop the profession. Research teams must guide and involve from the project’s inception.
- 3 November 2023
- Published by Springer Nature in BMC Primary Care
- Vol. 24 (1) , 1-11
Open AccessFactors influencing French community pharmacists’ willingness to participate in research projects: a mixed method study
Background: French community pharmacists are facing an increasing demand to provide a wider range of services to meet the needs of the population. These new missions must be evaluated by primary care research studies. This study aims to explore the factors that influence French community pharmacists’ willingness to participate in research projects. Methods: A mixed-method design was adopted for this study, comprising an initial quantitative online survey followed by semi-directed interviews. The investigation was conducted at two French faculties of pharmacy, Angers and Nantes, involving students in their 6th and final year of pharmacy education, and their community pharmacist tutors. The survey items were based on a study by Saini et al. and participants responded using five-point Likert scales. The semi-directed interviews were conducted after the quantitative analysis, only with volunteer and already graduated community pharmacists. Results: A total of 131 people participated in the quantitative analysis, comprising 75 students and 56 pharmacists. Pharmacists and students agreed on the significance of two key aspects: the research must possess a clear and meaningful purpose, and researchers must keep the pharmacists informed about the study’s results. Among the 27 proposed items, only three showed significantly different results between students and pharmacists. Moreover, 11 semi-structured interviews were conducted. Research in the community pharmacy domain is relatively new for many pharmacists. Despite limited training, their willingness to participate is contingent on being actively involved from the outset, receiving appropriate support and training. However, the research should be seamlessly integrated into their daily practice, without being too time-consuming and administratively burdensome. Time constraints emerged as the main obstacle, along with concerns about the availability of human resources. Pharmacists expressed strong motivation driven by the research topic’s relevance, and its potential impact on patients or the profession. While financial compensation is desirable, it did not appear to be the main criterion for participation in a study. Conclusions: French pharmacists are willing to participate in research projects to improve patient care and develop the profession. Research teams must guide and involve from the project’s inception.